Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
7 Lisdexamphetamine (Vyvanse) is currently approved for binge-eating disorder in adults aged 18 years and older and in children aged 6 years and older diagnosed with attention-deficit/hyperactivity disorder, though its mechanism of action in treating both indications is still unclear
This represents an emerging, off-label application requiring careful evaluation of surgical history, metabolic status, and nutritional adequacy
This makes it easier for clots to form
Patients who establish durable eating and exercise habits during medication tend to maintain 30-50 percent of their weight loss long-term
For someone taking a statin and losing weight on Mounjaro, your GP may check liver function periodically
US$ 24.81
US$ 29.49
US$ 22.85
US$ 29.55
